Her Majesty the Queen in the Right of Canada as Represented by the Minister of Health

Patent Applications and Registrations

Patent applications and USPTO patent grants for Her Majesty the Queen in the Right of Canada as Represented by the Minister of Health.The latest application filed is for "poxvirus host range protein k3 as a positive selection marker for generation of recombinant poxviruses, a therapeutic target for poxvirus infection and a therapeutic agent for pkr related diseases".

Company Profile

4.25.13

Her Majesty the Queen in the Right of Canada as Represented by the Minister of Health - Winnipeg N/A CA
HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF HEALTH - N/A
Her Majesty the Queen in Right of Canada As Represented by, the Minister of Health - Winnipeg Manitoba CA
HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY THE MINISTER OF HEALTH - Ottawa CA
Her Majesty the Queen in right of Canada, as represented by the Minister of Health - CA CA
Her Majesty the Queen in Right of Canada, as Represented by The Minister of Health -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthetic hemagglutinin as universal vaccine against infection by type B influenza viruses (IBV) Grant 11,413,345 - Li , et al. August 16, 2	2022-08-16
Methods of inducing an immune response against HIV-1 utilizing nucleic acids encoding polypeptides containing HIV-1 protease cleavage sites Grant 11,389,527 - Luo July 19, 2	2022-07-19
Poxvirus Host Range Protein K3 as a Positive Selection Marker for Generation of Recombinant Poxviruses, a Therapeutic Target for Poxvirus Infection and a Therapeutic Agent for PKR Related Diseases App 20210244739 - Cao; Jingxin	2021-08-12
Methods of preventing or treating filovirus and flavivirus diseases Grant 10,987,371 - Chretien , et al. April 27, 2	2021-04-27
Synthetic Hemagglutinin as Universal Vaccine Against Infection by Type B Influenza Viruses (IBV) App 20200306363 - Li; Xuguang ; et al.	2020-10-01
Protease Cleavage Site Peptides as an HIV Vaccine App 20200246269 - Kind Code	2020-08-06
Nanoparticles carrying immunogenic peptides targeting HIV-1 protease cleavage sites Grant 10,617,645 - Luo	2020-04-14
Protease Cleavage Site Peptides as an HIV Vaccine App 20190201342 - Luo; Ma	2019-07-04
Methods of inducing an immune response against HIV by administering immunogenic peptides obtained from protease cleavage sites Grant 10,285,942 - Luo	2019-05-14
Monoclonal Antibodies for Ebola and Marburg Viruses App 20180071389 - Jones; Steven ; et al.	2018-03-15
Monoclonal antibodies for Ebola and Marburg viruses Grant 9,861,696 - Jones , et al. January 9, 2	2018-01-09
Monoclonal antibodies to anthrax protective antigen Grant 9,512,205 - Tsang , et al. December 6, 2	2016-12-06
Reagents and methods for detecting influenza virus proteins Grant 9,427,462 - Li , et al. August 30, 2	2016-08-30
Derivatives of dillapiol and related monolignans and use thereof Grant 9,386,767 - Arnason , et al. July 12, 2	2016-07-12
Monoclonal Antibodies for Ebola and Marburg Viruses App 20160151492 - Jones; Steven ; et al.	2016-06-02
Monoclonal antibodies for Ebola and Marburg viruses Grant 9,249,214 - Jones , et al. February 2, 2	2016-02-02
Monoclonal Antibodies To Anthrax Protective Antigen App 20160002321 - Tsang; Raymond ; et al.	2016-01-07
Peptide adjuvants Grant 9,211,325 - Patel , et al. December 15, 2	2015-12-15
Monoclonal Antibodies for Ebola and Marburg Viruses App 20150344546 - Jones; Steven ; et al.	2015-12-03
Monoclonal antibodies for Ebola and Marburg viruses Grant 9,145,454 - Jones , et al. September 29, 2	2015-09-29
Reagents and Methods for Detecting Influenza Virus Proteins App 20150147784 - Li; Xuguang ; et al.	2015-05-28
Dispersive ultrasound technology as a diagnostic device for traumatic brain injuries Grant 8,834,376 - Stergiopoulos , et al. September 16, 2	2014-09-16
Optimized promoter sequence Grant 8,663,981 - Kobinger , et al. March 4, 2	2014-03-04
Derivatives Of Dillapiol And Related Monolignans And Use Thereof App 20130012477 - Arnason; John Thor ; et al.	2013-01-10
Method and system for aggregating and disseminating time-sensitive information Grant 7,685,097 - St. John , et al. March 23, 2	2010-03-23
Buoyancy-corrected gravimetric analysis system Grant 7,357,045 - Rasmussen , et al. April 15, 2	2008-04-15
Method and apparatus for reproducible dissolution testing of pharmaceutical products Grant 7,008,101 - Qureshi March 7, 2	2006-03-07
Micro extraction technique Grant 6,825,046 - Forsyth November 30, 2	2004-11-30
Low speed precision stirring/mixing device Grant 6,676,285 - Qureshi January 13, 2	2004-01-13
Method and apparatus for reproducible dissolution testing of pharmaceutical products App 20030235110 - Qureshi, Saeed A.	2003-12-25
Monoclonal antibody against estrogen stimulated leucine aminopeptidase Grant 6,649,743 - Pulido-Cejudo November 18, 2	2003-11-18
Low speed precision stirring/mixing device App 20030058735 - Qureshi, Saeed A.	2003-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.